Lisata Therapeutics | 424B5: Prospectus
Lisata Therapeutics | EFFECT: Others
Lisata Therapeutics | 424B5: Prospectus
Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Caladrius Biosciences | 424B3: Prospectus
Caladrius Biosciences | EFFECT: Others
Caladrius Biosciences | S-4/A: Registration of securities issued in business combination transactions (Amendment)
Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Caladrius Biosciences | S-4: Registration of securities issued in business combination transactions
Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Caladrius Biosciences | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Caladrius Biosciences | 424B5: Prospectus
Caladrius Biosciences | 424B2: Prospectus
Caladrius Biosciences | EFFECT: Others
Caladrius Biosciences | 424B5: Prospectus
Caladrius Biosciences | 424B5: Prospectus
Caladrius Biosciences | 424B5: Prospectus
Caladrius Biosciences | EFFECT: Others
No Data
No Data